Earnings Call · Q1 FY2022·2022-05-02

Q1 22EPS +0.56%·Rev n/aQ4 21EPS +9.81%·Rev n/aQ3 21EPS +21.92%·Rev n/aQ2 21EPS +20.00%·Rev n/a⚠ consensus missing

MEDIFAST INC MED

Dan Chard — Chairman and Chief Executive Officer

Jim Maloney — Chief Financial Officer

−2.1%1d on move date−2.7% vs SPY3d+7.6%5d+1.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MED calls or request research access.

More MED calls Browse calls Request research access